BioRegenx, Inc. (BRGX)
OTCMKTS
· Delayed Price · Currency is USD
0.0108
0.00 (0.00%)
At close: Mar 5, 2026
BioRegenx Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 0.05 | 0.06 | 0.13 | 0 | 0.88 | 0.59 |
| Cash & Short-Term Investments | 0.05 | 0.06 | 0.13 | 0 | 0.88 | 0.59 |
| Cash Growth | -33.01% | -53.43% | 18450.59% | -99.92% | 48.76% | - |
| Receivables | 0.06 | 0.01 | 0.1 | - | 0 | - |
| Inventory | 0.11 | 0.11 | 0.22 | - | 0.65 | 0.85 |
| Prepaid Expenses | 0.01 | 0.01 | 0.06 | - | 0.24 | 0.16 |
| Other Current Assets | 0.05 | 0.12 | 0.14 | - | 0.11 | 0.26 |
| Total Current Assets | 0.27 | 0.31 | 0.65 | 0 | 1.89 | 1.87 |
| Property, Plant & Equipment | 0.17 | 0.2 | 0.01 | - | 0.02 | - |
| Long-Term Investments | - | - | - | 0.02 | - | - |
| Other Intangible Assets | 0.73 | - | 0.05 | 0.04 | - | - |
| Other Long-Term Assets | - | - | 0.15 | - | 0.01 | 0.01 |
| Total Assets | 1.17 | 0.51 | 0.87 | 0.06 | 1.92 | 1.88 |
| Accounts Payable | 0.85 | 0.65 | 0.46 | 0.02 | 0.61 | 1.89 |
| Accrued Expenses | 0.91 | 0.88 | 0.64 | - | 1 | 0.72 |
| Short-Term Debt | 1.03 | 1.03 | 0.96 | - | 1.32 | 0.5 |
| Current Portion of Long-Term Debt | 1.04 | 0.88 | 0.38 | 0.05 | - | - |
| Current Unearned Revenue | 0.1 | 0.2 | 0.35 | - | 0.07 | - |
| Total Current Liabilities | 3.93 | 3.63 | 2.79 | 0.06 | 2.99 | 3.11 |
| Long-Term Debt | 0.18 | 0.25 | 0.15 | 0.2 | 2.19 | 0.77 |
| Total Liabilities | 4.81 | 3.89 | 2.94 | 0.26 | 5.18 | 3.89 |
| Common Stock | 0.96 | 1.23 | 0.77 | 0.27 | 0 | 0.01 |
| Additional Paid-In Capital | 31.49 | 30.97 | 9.68 | 2.44 | 2.7 | 0.41 |
| Retained Earnings | -36.1 | -35.57 | -12.52 | -2.92 | -5.96 | -0.56 |
| Comprehensive Income & Other | - | 0 | -0 | - | - | -1.86 |
| Total Common Equity | -3.65 | -3.38 | -2.07 | -0.21 | -3.26 | -2 |
| Shareholders' Equity | -3.65 | -3.38 | -2.07 | -0.2 | -3.26 | -2 |
| Total Liabilities & Equity | 1.17 | 0.51 | 0.87 | 0.06 | 1.92 | 1.88 |
| Total Debt | 2.25 | 2.16 | 1.49 | 0.24 | 3.51 | 1.27 |
| Net Cash (Debt) | -2.21 | -2.11 | -1.36 | -0.24 | -2.62 | -0.68 |
| Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.07 | -0.02 |
| Filing Date Shares Outstanding | 961.99 | 956.99 | 956.63 | 38.88 | 36.17 | 34.91 |
| Total Common Shares Outstanding | 961.99 | 956.99 | 956.63 | 38.58 | 36.17 | 34.91 |
| Working Capital | -3.66 | -3.33 | -2.13 | -0.06 | -1.11 | -1.24 |
| Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.09 | -0.06 |
| Tangible Book Value | -4.37 | -3.38 | -2.12 | -0.25 | -3.26 | -2 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.09 | -0.06 |
Source: S&P Capital IQ. Standard template. Financial Sources.